M. V. Panse

502 total citations
20 papers, 351 citations indexed

About

M. V. Panse is a scholar working on Endocrinology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. V. Panse has authored 20 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, 5 papers in Pharmacology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. V. Panse's work include Vibrio bacteria research studies (9 papers), Inflammatory mediators and NSAID effects (3 papers) and Pregnancy and preeclampsia studies (2 papers). M. V. Panse is often cited by papers focused on Vibrio bacteria research studies (9 papers), Inflammatory mediators and NSAID effects (3 papers) and Pregnancy and preeclampsia studies (2 papers). M. V. Panse collaborates with scholars based in Germany, India and United States. M. V. Panse's co-authors include Noton K. Dutta, Evelin Wacker, Dirk Wenzel, Gerald Wulf, Ulf K Radunski, Lorenz Truemper, Nobuya Inagaki, Bjoern Chapuy, Raphael Koch and Dagmar Haase and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

M. V. Panse

18 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. V. Panse Germany 11 119 85 66 54 40 20 351
Tomoko Shima Japan 12 101 0.8× 133 1.6× 17 0.3× 112 2.1× 56 1.4× 33 539
Susan Beckerdite United States 8 43 0.4× 260 3.1× 136 2.1× 9 0.2× 31 0.8× 8 475
Horacio A. Repetto Argentina 14 185 1.6× 80 0.9× 96 1.5× 10 0.2× 14 0.3× 29 435
Muhammad Yasir United Kingdom 12 69 0.6× 131 1.5× 32 0.5× 15 0.3× 60 1.5× 50 473
S Bunyaratvej Thailand 13 24 0.2× 97 1.1× 32 0.5× 26 0.5× 11 0.3× 30 436
Gregory H. Foster United States 10 180 1.5× 133 1.6× 144 2.2× 11 0.2× 22 0.6× 16 532
Chi-Hong Chu Taiwan 14 116 1.0× 147 1.7× 83 1.3× 39 0.7× 212 5.3× 27 640
Şule Karaman Türkiye 11 37 0.3× 139 1.6× 59 0.9× 17 0.3× 35 0.9× 33 494
Takumi Jikimoto Japan 10 19 0.2× 173 2.0× 43 0.7× 54 1.0× 15 0.4× 13 369
Karen Pickard United Kingdom 11 38 0.3× 289 3.4× 122 1.8× 15 0.3× 38 0.9× 15 695

Countries citing papers authored by M. V. Panse

Since Specialization
Citations

This map shows the geographic impact of M. V. Panse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. V. Panse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. V. Panse more than expected).

Fields of papers citing papers by M. V. Panse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. V. Panse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. V. Panse. The network helps show where M. V. Panse may publish in the future.

Co-authorship network of co-authors of M. V. Panse

This figure shows the co-authorship network connecting the top 25 collaborators of M. V. Panse. A scholar is included among the top collaborators of M. V. Panse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. V. Panse. M. V. Panse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panse, M. V., et al.. (2025). Unlikely Diagnosis of Pulmonary Embolism in Setting of Coumadin Failure. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A4383–A4383.
2.
Santiago, Lumarie, et al.. (2025). Navigating the Diagnosis and Management of Pleural Solitary Fibrous Tumors: A Case Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A6973–A6973.
3.
Padberg, Stephanie, Evelin Wacker, Reinhard Meister, et al.. (2014). Observational Cohort Study of Pregnancy Outcome after First-Trimester Exposure to Fluoroquinolones. Antimicrobial Agents and Chemotherapy. 58(8). 4392–4398. 38 indexed citations
4.
Hoeltzenbein, Maria, et al.. (2013). Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity. PLoS ONE. 8(6). e66637–e66637. 23 indexed citations
5.
Chapuy, Bjoern, M. V. Panse, Ulf K Radunski, et al.. (2009). ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug. Haematologica. 94(11). 1528–1536. 71 indexed citations
6.
Lakhani, Ali, et al.. (1990). An outbreak of food poisoning suspected to be caused by Vibrio fluvialis.. PubMed. 8(4). 163–5. 14 indexed citations
7.
Panse, M. V., et al.. (1988). An enzyme-linked immunoassay for thromboxane B2 and 6-oxo-PGF1 alpha using peroxidase as label.. PubMed. 47(10-11). S137–9. 5 indexed citations
8.
Panse, M. V., Helena Block, William Foster, & H.‐J. Mest. (1985). An improved malondialdehyde assay for estimation of thromboxane synthase activity in washed human blood platelets. Prostaglandins. 30(6). 1031–1040. 19 indexed citations
9.
Beitz, J., M. V. Panse, & W Förster. (1983). Low density lipoprotein (LDL) from male volunteers stimulated the thromboxane formation by human platelets. Prostaglandins Leukotrienes and Medicine. 10(4). 443–448. 15 indexed citations
10.
Beitz, J., et al.. (1983). Inhibition of prostaglandin I2 (PGI2) formation by LDL-cholesterol or LDL-peroxides?. Prostaglandins. 26(6). 885–892. 6 indexed citations
11.
Panse, M. V., et al.. (1971). Usefulness of a medicinal plant (Bragantia wallichi) in experimental cholera.. PubMed. 59(8). 1190–3. 2 indexed citations
12.
Kabins, S. A., M. V. Panse, & Sidney Cohen. (1971). Role of R Factor and Bacterial Host in Sulfonamide Resistance Mediated by R Factor in Escherichia coli. The Journal of Infectious Diseases. 123(2). 158–168. 2 indexed citations
13.
Panse, M. V. & Noton K. Dutta. (1964). Cholera Vaccines and Placental Transmission of Antibodies. The Journal of Immunology. 93(2). 243–245. 8 indexed citations
14.
Panse, M. V., et al.. (1964). Passive Immunity in Experimental Cholera. The Journal of Infectious Diseases. 114(1). 26–30. 11 indexed citations
15.
Dutta, Noton K., et al.. (1963). Choleragenic Property of Certain Strains of El Tor, Non-agglutinable, and Water Vibrios Confirmed Experimentally. BMJ. 1(5339). 1200–1203. 19 indexed citations
16.
Dutta, Noton K. & M. V. Panse. (1963). An experimental study on the usefulness of bacteriophage in the prophylaxis and treatment of cholera.. PubMed. 28(3). 357–60. 4 indexed citations
17.
Dutta, Noton K. & M. V. Panse. (1962). Usefulness of Berberine (an Alkaloid from Berberis aristata) in the Treatment of Cholera (Experimental).. The Indian Journal of Medical Research. 50(5). 22 indexed citations
18.
Panse, M. V. & Noton K. Dutta. (1961). Excretion of Toxin with Stools of Cholera Patients. The Journal of Infectious Diseases. 109(1). 81–84. 15 indexed citations
19.
Dutta, Noton K., et al.. (1959). ROLE OF CHOLERA TOXIN IN EXPERIMENTAL CHOLERA. Journal of Bacteriology. 78(4). 594–595. 76 indexed citations
20.
Panse, M. V., et al.. (1959). Cholera epidemic in Poona. Bacteriological investigation.. PubMed. 13. 699–703. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026